Global Cord Blood Corporation (CORBF)
OTCMKTS · Delayed Price · Currency is USD
1.050
-0.700 (-40.00%)
Aug 27, 2025, 2:35 PM EDT
Global Cord Blood Market Cap
Global Cord Blood has a market cap or net worth of $140.61 million as of August 28, 2025. Its market cap has decreased by -16.00% in one year.
Market Cap
140.61M
Enterprise Value
n/a
Revenue
196.10M
Ranking
n/a
PE Ratio
1.62
Stock Price
$1.05
Market Cap Chart
Since July 1, 2009, Global Cord Blood's market cap has decreased from 968.15M to 140.61M, a decrease of -85.48%. That is a compound annual growth rate of -11.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 140.61M | -30.00% |
| Dec 31, 2024 | 200.87M | 22.95% |
| Dec 29, 2023 | 163.38M | -67.92% |
| Dec 31, 2021 | 509.30M | 12.94% |
| Dec 31, 2020 | 450.95M | -25.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 636.43M |
| Elite Pharmaceuticals | 594.22M |
| CytoDyn | 388.66M |
| Northwest Biotherapeutics | 357.21M |
| American Oncology Network | 357.05M |